Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Arcellx, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ACLX is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 240
- +26 vs. Q4 2025
- Shares held
- 57.0M
- −5.51M (−8.8%) vs. Q4 2025
- Total value
- $6.52B
- +$2.44B (+59.9%) vs. Q4 2025
- New holders
- 97
- 62 more added
- Sold out
- 71
- 56 more reduced
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $3.43M |
| Q1 2026 | 240 | $6.52B |
| Q4 2025 | 218 | $4.34B |
| Q3 2025 | 209 | $5.18B |
| Q2 2025 | 203 | $4.01B |
| Q1 2025 | 198 | $4.04B |
| Q4 2024 | 211 | $4.54B |
| Q3 2024 | 186 | $4.13B |
| Q2 2024 | 167 | $2.77B |
| Q1 2024 | 183 | $3.27B |
| Q4 2023 | 156 | $2.59B |
| Q3 2023 | 136 | $1.71B |
| Q2 2023 | 138 | $1.52B |
| Q1 2023 | 117 | $1.40B |
| Q4 2022 | 125 | $1.30B |
| Q3 2022 | 74 | $781.8M |
| Q2 2022 | 68 | $621.5M |
| Q1 2022 | 49 | $357.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Arcellx, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 0 | $0 | 0.00% | −1,076−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −697−100.0% | Sold out |
| Ramirez Asset Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −176−100.0% | Sold out |
| Kemnay Advisory Services Inc. | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |